Scarica l'app Stockscreener
5.41
4.42%
-0.25
Dopo l'orario di chiusura:
5.41
Precedente Chiudi:
$5.66
Aprire:
$5.7
Volume 24 ore:
459.06K
Relative Volume:
0.17
Capitalizzazione di mercato:
$275.63M
Reddito:
$15.84M
Utile/perdita netta:
$-308.48M
Rapporto P/E:
-1.3731
EPS:
-3.94
Flusso di cassa netto:
$-153.08M
1 W Prestazione:
+0.74%
1M Prestazione:
-18.15%
6M Prestazione:
+4.64%
1 anno Prestazione:
-31.69%
Intervallo 1D:
$5.36
$5.73
Intervallo di 1 settimana:
$5.20
$5.79
Portata 52W:
$3.73
$11.35
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
Acadian Asset Management LLC Sells 99,744 Shares of uniQure (NASDAQ:QURE) - MarketBeat
(QURE) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Acadian Asset Management LLC Has $2.30 Million Position in uniQure (NASDAQ:QURE) - Defense World
uniQure (NASDAQ:QURE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Institutional owners may take dramatic actions as uniQure N.V.'s (NASDAQ:QURE) recent 11% drop adds to one-year losses - Simply Wall St
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology - GlobeNewswire Inc.
Trading (QURE) With Integrated Risk Controls - Stock Traders Daily
uniQure N.V.’s Banking’s 100-Day Moving Average at 5.76: Will the Stock Break Through? - The InvestChronicle
Assenagon Asset Management S.A. Makes New Investment in uniQure (NASDAQ:QURE) - MarketBeat
uniQure Forecasted to Post FY2024 Earnings of ($4.84) Per Share (NASDAQ:QURE) - MarketBeat
FY2024 Earnings Forecast for uniQure Issued By HC Wainwright (NASDAQ:QURE) - Defense World
uniQure retains PT with Buy rating on gene therapy prospects - Investing.com
HC Wainwright Reaffirms "Buy" Rating for uniQure (NASDAQ:QURE) - MarketBeat
HC Wainwright Reaffirms “Buy” Rating for uniQure (NASDAQ:QURE) - Defense World
Is uniQure N.V. (QURE) worth investing in despite its undervalued state? - US Post News
QURE (uniQure NV) Cash From Other Investing Activities : $-366.44 Mil (TTM As of Jun. 2024) - GuruFocus.com
QURE (uniQure NV) Total Inventories : $0.00 Mil (As of Jun. 2024) - GuruFocus.com
uniQure NV (STU:UQ1) 3-Year EPS without NRI Growth Rate : -36.20% (As of Jun. 2024) - GuruFocus.com
QURE (uniQure NV) Change In Receivables : $90.64 Mil (TTM As of Jun. 2024) - GuruFocus.com
Vanguard Group Inc. Raises Position in uniQure (NASDAQ:QURE) - MarketBeat
Vanguard Group Inc. Acquires 109,740 Shares of uniQure (NASDAQ:QURE) - Defense World
uniQure (NASDAQ:QURE) Short Interest Up 20.1% in July - MarketBeat
uniQure NV (STU:UQ1) Inventory-to-Revenue : 0.68 (As of Jun. 2024) - GuruFocus.com
uniQure NV (STU:UQ1) Financial Strength : 4 (As of Jun. 2024) - GuruFocus.com
uniQure Begins Phase I/IIa Trial for Fabry Disease Treatment - TipRanks
uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - GlobeNewswire
uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - StockTitan
Analysts Set uniQure (NASDAQ:QURE) Price Target at $18.60 - MarketBeat
uniQure (NASDAQ:QURE) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Implied Volatility Surging for uniQure (QURE) Stock Options - Yahoo Singapore News
Cantor Fitzgerald Weighs in on uniQure's FY2024 Earnings (NASDAQ:QURE) - MarketBeat
uniQure (NASDAQ:QURE) Expected to Earn FY2024 Earnings of ($3.14) Per Share - Defense World
StockNews.com Upgrades uniQure (NASDAQ:QURE) to “Sell” - Defense World
How to Take Advantage of moves in (QURE) - Stock Traders Daily
uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity (QURE) - Seeking Alpha
uniQure (NASDAQ:QURE) Upgraded to "Sell" by StockNews.com - MarketBeat
Leerink Partnrs Comments on uniQure's Q3 2025 Earnings (NASDAQ:QURE) - MarketBeat
Analysts Offer Predictions for uniQure’s Q3 2025 Earnings (NASDAQ:QURE) - Defense World
The Goldman Sachs Group Increases uniQure (NASDAQ:QURE) Price Target to $10.00 - Defense World
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Simply Wall St
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
UniQure to cut 65% of workforce, or 300 jobs, in major restructuring (NASDAQ:QURE) - Seeking Alpha
uniQure (NASDAQ:QURE) PT Raised to $10.00 at The Goldman Sachs Group - MarketBeat
UniQure Keeps Cutting Costs With 300 More Jobs To Go - Scrip
UniQure: Q2 Earnings Snapshot - Darien Times
UniQure: Q2 Earnings Snapshot - San Antonio Express-News
UniQure: Q2 Earnings Snapshot - New Haven Register
UniQure: Q2 Earnings Snapshot - The Advocate
UniQure: Q2 Earnings Snapshot - The Washington Post
UniQure: Q2 Earnings Snapshot - San Francisco Chronicle
UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Uniqure N V Azioni (QURE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| CALOZ PIERRE | Chief Operating Officer |
Jun 17 '24 |
Sale |
4.81 |
2,936 |
14,122 |
115,707 |
| KLEMT CHRISTIAN | Chief Financial Officer |
Jun 17 '24 |
Sale |
4.80 |
1,611 |
7,733 |
164,837 |
| POST LEONARD E | Director |
Jun 13 '24 |
Sale |
5.14 |
2,222 |
11,421 |
15,999 |
| Potts Jeannette | Chief Legal Officer |
Jun 13 '24 |
Sale |
4.98 |
4,781 |
23,809 |
91,819 |
| Springhorn Jeremy P. | Director |
Jun 13 '24 |
Sale |
5.12 |
2,231 |
11,423 |
23,756 |
| Meek David D. | Director |
Jun 13 '24 |
Sale |
5.12 |
2,229 |
11,412 |
20,252 |
| Balachandran Madhavan | Director |
Jun 13 '24 |
Sale |
5.12 |
2,231 |
11,423 |
23,759 |
| Soteropoulos Paula | Director |
Jun 13 '24 |
Sale |
5.14 |
2,220 |
11,411 |
20,203 |
| Gut Robert | Director |
Jun 13 '24 |
Sale |
5.12 |
3,504 |
17,940 |
44,165 |
| Kaye Jack | Director |
Jun 13 '24 |
Sale |
5.16 |
2,218 |
11,445 |
6,501 |
1.10%
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):